Challenges in Acute Ischemic Stroke Clinical Trials
- 26 August 2012
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 14 (6) , 761-766
Abstract
There have been only 3 positive Phase III randomized clinical trials in acute ischemic stroke, all reperfusion therapies (NINDS; PROACT II; ECASS III). The only approved acute stroke therapy is <3-hour IV tPA. Although numerous compounds have shown benefit in animal models of brain infarction, there has never been a positive Phase III randomized clinical trial of a neuroprotectant in acute ischemic stroke. There are many challenges to acute stroke clinical trials but chief among these are the very short therapeutic window (“time is brain”) and the issue of stroke heterogeneity. Stroke is a syndrome and only a very small percentage of all stroke patients present to hospitals in time to consider reperfusion therapy. Many drugs have been rushed to trial prematurely based on inadequate preclinical testing. Many trials have been seriously underpowered due to overly optimistic treatment expectations and the risk of brain hemorrhage has precluded aggressive multimodal treatment strategies. Rather than simply relying on a clock, new imaging methods are being developed to identify patients with “tissue at risk” and “salvageable brain” regardless of time of stroke onset. The 7 STAIR conferences have been convened to address these and other challenges to acute ischemic stroke trial design and completion.Keywords
This publication has 20 references indexed in Scilit:
- Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective TherapiesStroke, 2011
- New Approaches to Neuroprotective Drug DevelopmentStroke, 2011
- Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy TrialsStroke, 2009
- The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) HoursStroke, 2009
- The 2007 Feinberg LectureStroke, 2008
- Recommendations From the STAIR V Meeting on Acute Stroke Trials, Technology and OutcomesStroke, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Recommendations for Advancing Development of Acute Stroke TherapiesStroke, 2003
- Recommendations for Clinical Trial Evaluation of Acute Stroke TherapiesStroke, 2001
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999